Skip to main content

Table 1 Molecular targets of miR-132 during tumor progressions

From: Molecular mechanisms of the microRNA-132 during tumor progressions

Study

Year

Type

Gene

Target

Samples

MiR-132 function

Zhang et al. [23]

2014

Breast

miR-132

HN1

10 NT*

NMuMG, 4T1, MDA-MB-231, and MCF10A cell lines

Tumor suppressor

Lian et al. [119]

2016

Laryngeal

miR-132

FOXO1

10 NT

Hep-G2 and AMC-HN-8 cell lines

Oncogene

Han et al. [132]

2020

Retinoblastoma

ILF3-AS1

miR-132

50 NT

Y79, HXO-RB44, SO-RB50, and RB1 cell lines

Tumor suppressor

Zhang et al. [129]

2020

Hepatocellular

LINC00160

miR-132

68 NT

HCCLM3, Huh7, Hep3B, and MHCC97 cell lines

Tumor suppressor

Zhang et al. [123]

2019

Pancreatic

miR-132

PTEN

60 NT

PAN-1, KLM-1, and PaCa-2 cell lines

Oncogene

Renjie et al. [45]

2015

Pituitary

miR-132

SOX5

16 T

MMQ and GH3 cell lines

Tumor suppressor

Xie et al. [124]

2018

Breast

miR-132

PTEN

53 NT

MCF-7 cell line

Oncogene

Chen et al. [94]

2016

Glioma

miR-132

TTK

46 T and 9 N

U87 cell line

Tumor suppressor

Song et al. [140]

2017

Colorectal

XIST

miR-132

50 NT

SW480, SW620, LOVO,HT29, and HCT116 cell lines

Tumor suppressor

Li et al. [68]

2016

Glioma

miR-132

SIRT1

U251 and U87 cell lines

Tumor suppressor

Zhao et al. [144]

2019

Pancreatic

miR-132

SHH

23 T and 25 N

MiaPaCe-2a cell line

Oncogene

Zhang et al. [79]

2019

Ovarian

miR-132

BMI1

SKOV3

Tumor suppressor

Xue et al. [43]

2020

Nasopharyngeal

LINC01551

miR-132

24 NT

HNE1, SUNE2, HONE1, CNE2, and 6-10B cell lines

Tumor suppressor

Liu et al. [89]

2018

Colorectal

MIAT

miR-132

30 NT

Ht29, SW480, and LOVO cell lines

Tumor suppressor

Zhou et al. [51]

2018

Glioma

NEAT1

miR-132

14 T and 5 N

U87, U251, SHG-44, and U-118MG cell lines

Tumor suppressor

Liu et al. [42]

2020

Pancreatic

PTTG3P

miR-132

60 NT

AsPc-1, BxPC-3, CaPAN-2, MiaPaCa-2, PANC-1, and SW1990 cell lines

Oncogene

Chen et al. [36]

2019

Thyroid

miR-132

FOXA1

30 NT

TPC1 and GLAG-66 cell lines

Tumor suppressor

Tian et al. [64]

2016

Ovarian

miR-132

E2F5

32 NT

SKOV3, OVCAR3, and A2780 cell lines

Tumor suppressor

Guo et al. [84]

2018

Lung

miR-132

USP9X

A549 and NCI-1299 cell lines

Tumor suppressor

Wang et al. [35]

2018

Breast

miR-132

FOXA1

30 NT

SK-BR3 and MDA-MB-468 cell lines

Tumor suppressor

Li et al. [128]

2019

Breast

miR-132

LAPTM4B

131 T and 87 N

MCF-7, MCF-10A, ZR-75–1, T470, and MDA-MB-231 cell lines

Tumor suppressor

Lei et al. [147]

2015

Hepatocellular

miR-132

YAP

Huh7 and HepG2 cell lines

Tumor suppressor

Liu et al. [49]

2019

Bladder

CIRC-DOCK1

miR-132

23 T and 32 N

BIU-87, EJ-m3, T24, and 5673 cell lines

Tumor suppressor

Qu et al. [108]

2016

Prostate

miR-132

GLUT1

PC-3 and DU-145 cell lines

Tumor suppressor

Geng et al. [112]

2016

Astrocytoma

miR-132

PEA15

U251 and U87 cell lines

Tumor suppressor

Chen et al. [126]

2018

Thyroid

miR-132

CSDE1

BCPAP, TPC1, and 8505c cell lines

Tumor suppressor

Cheng et al. [90]

2017

Glioblastoma

miR-132

TUSC3

U87MG

Oncogene

Liu et al. [58]

2015

Osteosarcoma

miR-132

SOX4

MG63, HOS, 143B, U2OS, and SaOS-2 cell lines

Tumor suppressor

Abukiwan et al. [136]

2019

Pancreatic

miR-132

TGFβ

35 NT

AsPC-1 and PANC-1 cell lines

Oncogene

Zhao et al. [130]

2015

Cervical

miR-132

SMAD2

20 NT

HeLa and C33A cell lines

Tumor suppressor

Li et al. [61]

2015

Lung

miR-132

SOX4

H460, A549, and YTMLC-9 cell lines

Tumor suppressor

Chen et al. [133]

2020

Oral

miR-132

TGFβ

37 NT

SCC-9 and CAL-27 cell lines

Tumor suppressor

Zhang et al. [70]

2019

Colorectal

SNHG5

miR-132

25 NT

RKO, SW480, and LOVO cell lines

Tumor suppressor

Li et al. [30]

2015

Gastric

miR-132

FOXO1

28 NT

AGS and SNU-5 cell lines

Oncogene

Lin et al. [74]

2016

Ovarian

miR-132

CDH2, VIM

SKOV3 and OV2008 cell lines

Tumor suppressor

Liu et al. [139]

2019

Colorectal

miR-132

ERK1

NCM460, LOVO, and SW480 cell lines

Tumor suppressor

Liu et al. [102]

2017

Gastric

miR-132

CD44, FN1

201 NT

BGC823, AGS, and HGC27 cell lines

Tumor suppressor

He et al. [107]

2017

Gastric

miR-132

MUC13

40 NT

MKN28 cell line

Tumor suppressor

Huang et al. [62]

2020

Hepatocellular

miR-132

SOX4

HepG2, Huh7, and HccLM3 cell lines

Tumor suppressor

Liu et al. [78]

2017

Cervical

miR-132

BMI1

104 NT

HeLa, SiHa, and C33A cell lines

Tumor suppressor

Zhang et al. [80]

2018

Lung

SOX2OT

miR-132

48 NT

A549, H1299, NCI-H460, and HCC-827 cell lines

Tumor suppressor

Wei et al. [131]

2019

Bladder

miR-132

SMAD2

32 NT

T24 cell line

Tumor suppressor

He et al. [86]

2020

Colorectal

SNHG16

miR-132

50 NT

SW480 and SW620 cell lines

Tumor suppressor

Fu et al. [60]

2016

Prostate

miR-132

SOX4

57 NT

LnCap and VCap cell lines

Tumor suppressor

Zheng et al. [81]

2014

Colorectal

miR-132

ZEB2

62 NT

HT29, LOVO, HTC116, SW480, and SW620 cell lines

Tumor suppressor

Wang et al. [113]

2014

Osteosarcoma

miR-132

CCNE1

10 NT

HOS, MG63, 143B, and Saos-2 cell lines

Tumor suppressor

Li et al. [32]

2016

Nasopharyngeal

miR-132

FOXA1

CNE2

Tumor suppressor

  1. * Tumor (T) tissues and Normal (N) margins